ABSTRACT The purpose of this study was to investigate whether dietary curcumin affects lipid metabolism in the liver of broiler chickens. Four treatment groups were formed from 1200 1-day-old broiler chickens, including a base diet (control, supplemented with 0 mg/kg curcumin), 500 mg/kg, 1,000 mg/kg, and 2,000 mg/kg dietary curcumin, for 49 d. At the end of experiment, each group of 50 chickens were sampled and analyzed. Compared with the control group, the results have showed that body weight, average daily weight gain, absolute and relative liver weight significantly decreased in the 1,000 and 2,000 mg/kg curcumin groups (P < 0.05). The absolute and relative abdominal fat weight were significantly decreased in the 2,000 mg/kg curcumin group (P < 0.05). The concentrations of plasma low-density lipoprotein cholesterol (P < 0.05) and plasma and hepatic triglyceride concentrations (P < 0.01) were markedly decreased in the 2,000 mg/kg curcumin group. The hepatic nonesterified fatty acid concentration (P < 0.05) and the hepatic glycogen (P < 0.05) and liver hepatic lipase activities (P < 0.01) were significantly increased in the 1,000 and 2,000 mg/kg curcumin groups. The plasma-free triiodothyronine and thyroxine concentrations were significantly increased in the 2,000 mg/kg curcumin group (P < 0.05). The gene expression levels of fatty acid synthase (FAS) and sterol regulatory element binding protein-1c (SREBP-1c) were significantly decreased in all curcumin groups (P < 0.05), but the gene expression levels of acetyl CoA carboxylase (ACC) and ATPcitrate lyase (ACLY) were significantly decreased only in the 2,000 mg/kg curcumin group (P < 0.05). The expression levels of peroxisome proliferators-activated receptor α (PPARα) and carnitine palmitoyl transferase-I (CPT-I) were significantly increased in the 1,000 and 2,000 mg/kg curcumin groups (P < 0.05). These results indicated that curcumin plays an important role in reduction abdominal fat deposition by decreasing the hepatic and plasma lipid profile and affecting the expression levels of genes related to lipogenesis and lipolysis including ACC, FAS, SREBP-1c, ACLY, PPARα, and CPT-I.
INTRODUCTION
Poultry differs from mammals in that the bird liver is the main organ involved in de novo fatty acid synthesis; in young chicks, the liver accounts for the production of 95% of lipid synthesis, which are deposited in adipose tissue or other organs (Leveille, 1969; Griffin et al., 1992; Jacobs et al., 2010) . Previous studies have shown that fat deposition can be altered by different lipid metabolic pathways, especially in genes involved in liver fatty acid metabolism (Leclercq et al., 1990) . Fatty acid synthesis is the creation of fatty acids from acetyl-CoA and NADPH through the action of enzymes called fatty acid synthase (FAS) . This process includes the fatty acids and cholesterol, which could convert from carbohydrates predominantly in the liver, which required an important intermediary via the conversion of pyruvate into acetyl-CoA in the mitochondrion. However, the fatty acid was not occurring directly in the cytosol. During the fatty acid synthesis process, the acetyl CoA needs to be transported from mitochondria into cytosol where synthesis of fatty acids and cholesterol requires the participation of many key enzymes including the sterol regulatory element binding protein-1c , acetyl CoA carboxylase (ACC), ATP-citrate lyase (ACLY), carnitine palmitoyl transferase-I (CPT-I), and peroxisome proliferators-activated receptor α (PPARα) (Shi et al., 2000; Louet et al., 2001; Tong, 2005; Ferre and 422 Foufelle, 2007) . Previous studies have indicated that transcription factors such as SREBP1c can directly promote lipogenic enzyme gene transcription such as ACC gene expression (Abu-Elheiga et al., 2001; Ishii et al., 2004) .
Previous studies indicated that curcumin is a potent regulator of insulin receptor substrate-1 and nuclear ubiquitin I, which inhibit the PPARα pathways (Liu et al., 2013; Ye et al., 2014) , limit fatty acid synthesis, increase hepatic glycogen synthesis, and decrease BW gain (Dvivedi et al., 2011; Bradford, 2013; Wang et al., 2015) . Curcumin regulation of lipid metabolism or lipid profiles in animal model and cell cultures has been previously investigated (Rukkumani et al., 2005; Mahfouz et al., 2009; Pettan-Brewer et al., 2011; Metzler et al., 2013) , but the underlying mechanisms of the effects of curcumin are not fully understood. Further research is necessary to elucidate the regulatory mechanisms of curcumin and lipid metabolism. Therefore, the aim of the present study was to explore the effect of curcumin on the expression of genes associated with hepatic lipid metabolism, which might help to identify the possible mechanism of curcumin for decreasing fat deposition in broiler chickens.
MATERIALS AND METHODS

Animal and Experimental Model
Male 1-day-old broiler chickens (Ross 308, N = 1200) were weighed and allocated to 4 treatment groups. Every group contains 3 feeding rooms, which contains 100 broiler chickens in each room. During the finishing phase, the 4 groups were supplemented with 0, 500, 1,000, or 2,000 mg/kg dietary curcumin. The chickens were fed the same basal diet ad libitum for 49 d (starting phase days 1 to 21 d and finishing phase days 22 to 49 d). The dietary nutrient levels were based on National Research Council-recommended nutrient requirements for broiler chickens (Table 1) (Yang et al., 2006) . All animal procedures were approved by the Fujian Agriculture and Forestry University Animal Care and Use Committee. The 25 chickens were housed in each lighted coops with the suitable temperature and humidity conditions (Xie et al., 2017) . These chickens were weighed every week to determine the average daily weight gain (ADG). Daily feed consumption was recorded per replicate by discarding the uneaten feed and replenishing the fresh feed, and the average daily feed intake (ADFI) and the feed conversion ratio (FCR) were determined. At the end of the experiment, the chickens were deprived of feed for 12 h, weighed, and sacrificed by the random selection of 50 birds from every group. The abdominal fat pad, liver, and pectoral and leg muscles were removed and weighed. Plasma and liver samples were obtained and stored at -20
• C and -78
• C, respectively, until analysis. 
Measurement of the Plasma lipid Profile
Plasma glucagon (GLU), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) contents were determined using colorimetric methods and a Beckman Kurt AU5800 series automatic biochemical analyzer (Beckman Kurt). The non-esterified fatty acid (NEFA) concentration was measured by a colorimetric method using a commercial kit purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The detection procedure and key technology was according to the manufacturer's instructions. The concentrations of insulin (INS), triiodothyronine (T3), thyroxine (T4), free triiodothyronine (FT3), and free thyroxine (FT4) were determined by the ELISA method. The ELISA kits were bought from the Shanghai Langdun Bioengineering Institute (Shanghai, China) and measured according to the instruction manual.
Measurement of the Hepatic Lipid Profile
The hepatic lipid profile was determined using homogenized liver samples (100 mg) with a mixture of chloroform and methanol (2:1, v/v). The mixture samples were rested 24 h. Subsequently, the chloroform and methanol phase of the extract were used to determine lipid profiles including TG, TC, and NEFA, and hepatic lipase (HL) at wavelength of 550 and 440 nm according to instruction manual of the commercial kits, respectively. These kits were purchased from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
One unit of HL enzyme activity represents 1 mg of tissue protein releasing 1 μmol of fatty acid per hour.
RNA Extraction, cDNA Synthesis and qPCR
Total RNA was extracted from the liver tissue samples using the TRIzol reagent (Invitrogen), and the concentration was quantified by measuring the absorbance at 260 nm in a spectrophotometer (Eppendorf Biotechnology, Hamburg, Germany). The mRNA expression in the liver tissue was determined by qPCR and the 2 − Ct method according to our previous study (Xie et al., 2015) . Then, the reverse transcription and qPCR mixtures were prepared on ice according to the manufacturer's instructions. They were carried out on a MyiQ2 PCR system (Bio-Rad). The primers were designed with the Primer 5.0 software and synthesized by Sangon Biotech (Shanghai, China), and they are listed in Table 2 .
Statistical Analysis
The results were expressed as the mean ± SEM. The final dataset was analyzed using ANOVA followed by a multiple range test, using the Statistical Packages for Social Science 20.0. A replicate was considered the experimental unit for the entire index determined (n = 50). Significant or extremely significant differences were indicated by P < 0.05 or P < 0.01.
RESULTS
Growth Performance
As shown in Table 3 , the BW and ADG in the 1,000 and 2,000 mg/kg curcumin groups were significantly (P < 0.05) lower than those in the control. The BW in the 2,000 mg/kg curcumin group was significantly decreased compared with those in the in the 500 mg/kg curcumin group. The ADFI was decreased in the 500 and 1,000 mg/kg curcumin group compared with the control group, but was increased in the 2,000 mg/kg curcumin group. The FCR in the 1,000 and 2,000 mg/kg curcumin groups were significantly (P < 0.05) higher than those in the control and 500 mg/kg curcumin group.
Carcass Composition
As shown in Table 4 , the absolute and relative abdominal fat weights were significantly decreased in the 2000 mg/kg curcumin group compared with the control group (P < 0.05). The absolute and relative liver weights were significantly (P < 0.05) lower in the 1,000 and 2,000 mg/kg curcumin group. The relative weight of pectoral and leg muscles was decreased in the 500, 1,000, and 2,000 mg/kg curcumin group compared with the control group. However, there was no significant difference about the results of this reduced based on the Table 4 (P > 0.05).
Lipid Profile
The concentrations of plasma TG (P < 0.01) and hepatic TG (P < 0.05) were significantly decreased in the 2,000 mg/kg curcumin group ( Figure 1A ) compared with the control group. The plasma TC concentration was decreased in the 1,000 and 2,000 mg/kg curcumin groups compared with the control group ( Figure 1B) . The plasma NEFA content was decreased in the 500 mg/kg curcumin group, but increased in the 1,000 and 2,000 mg/kg curcumin groups. The hepatic NEFA content was significantly increased in the 1,000 and 2,000 mg/kg curcumin groups (P < 0.05 and P < 0.01, respectively) compared with the control group ( Figure 1C) . The plasma LDL-C content was significantly decreased in the 2,000 mg/kg curcumin group (P < 0.05) compared with the control group (Figure 1D ), but the plasma HDL-C content was higher in the 2,000 mg/kg curcumin group than in the control group ( Figure 1D ). The hepatic HL activity was significantly increased in the 1,000 and 2,000 mg/kg curcumin groups (P < 0.01) compared with the control group ( Figure 1E ). The hepatic glycogen content was significantly increased in the 1,000 and 2,000 mg/kg curcumin groups (P < 0.05) compared with the control group ( Figure 1F ).
Plasma Hormone Concentrations
As shown in Table 5 , the plasma T3 concentration was not significantly different in any curcumin group compared with the control group (P > 0.05), but the plasma FT3 concentration was significantly increased in the 2,000 mg/kg curcumin group (P < 0.05). The plasma T4 concentration was significantly increased in the 2,000 mg/kg curcumin group (P < 0.05), whereas the FT4 concentration was not significantly different between the curcumin groups and the control group (P > 0.05). The general trend of plasma INS and GLU concentrations is consistent with the results for the plasma T3 and FT4 content.
Expression of Lipid Metabolism Genes
The results showed that the gene expression levels of FAS (Figure 2A ) and SREBP-1c ( Figure 2B ) were significantly downregulated in all curcumin groups (P < 0.05 and P < 0.01, respectively), but the gene expression levels of ACLY ( Figure 2C ) and ACC ( Figure 2D ) were significantly downregulated only in the 2,000 mg/kg curcumin group (P < 0.05) compared with the control group. The expression of CPT-1 was unaffected in the curcumin-treated group of 500 mg/kg (P > 0.05, Figure 2E ), but was significantly increased in the curcumin-treated groups of 1,000 mg/kg (P < 0.05, Figure 2E ) and 2,000 mg/kg (P < 0.01, Figure 2E ) compared with the control group. The changing trend of the PPARα gene expression was similar to the expression of CPT-1, but Note, data are presented as mean ± SEM. Each group of 50 chickens was selected at the age of 49 d. * P < 0.05 indicates statistically significant differences when compared with the control group. # P < 0.05 indicates statistically significant differences when compared with the curcumin 500 mg/kg group. BW = body weight; ADG = average daily gain; ADFI = average daily feed intake; FCR = feed conversion ratio. was significantly increased in the curcumin-treated groups of 1,000 mg/kg (P < 0.05) and 2,000 mg/kg (P < 0.01) compared with the control group ( Figure 2F ).
DISCUSSION
Curcumin is an extract from the turmeric rhizome and is widely used as an ingredient in nutritional supplements to reduce food intake, appetite, and BW; increase the browning of white adipose tissue; and inhibit adipogenesis (Ejaz et al., 2009; Bradford, 2013; Di Pierro et al., 2015) . Previous studies have reported that curcumin safely promotes weight loss in laboratory animals (Kang et al., 2011) and humans (Di Pierro et al., 2015) and suggest that the regulation of food intake may be a major weight management mechanism of curcumin. The present results indicated that the BW of broiler chickens was reduced. FT3 and T4 are thyroid hormones and are recognized as key metabolic hormones associated with energy production (Hornick et al., 2000; Smith et al., 2002) . Previous studies have indicated that reducing circulating thyroid hormone levels lowers the metabolic rate as a mechanism to protect the body's energy reserves (Buyse et al., 2002) . Presumably, the curcumin treatment of broiler chickens increased thermogenesis to regulate BW. Thus, curcumin affected BW not only via feed intake but also by increasing the plasma concentrations of thyroid hormones. Thus, we presume that the BW reduction could be due to a curcumin-related decrease in the fat deposition in broiler chickens.
Previous studies have reported that the relative liver weight was lower in rats fed a mixture of soy Note, data are presented as means ± SEM. Each group of 50 chickens was selected at the age of 49 d. * P < 0.05 indicates statistically significant differences when compared with control group. The abbreviations are as follows: T3, triiodothyronine; T4, thyroxine; FT3, free triiodothyronine; FT4, free thyroxine.
peptide and L-carnitine by effectively lowering blood and hepatic lipid concentrations (Kim et al., 2008) . Previous result showed that the serum TG and LDL-C concentrations (Hayamizu et al., 2003) , these results in the present was also reduced. In the present study, curcumin-treated groups increased the liver NEFA concentration and decreased the liver TG concentration. These changes were related with ACLY gene expression, which decreased in broiler chickens after curcumin treatment. ACLY is an important enzyme in fatty acid biosynthesis that converts citrate to acetyl CoA (Elshourbagy et al., 1992) . Inhibition of ACLY could decrease the transformation of citrate into acetyl CoA, which is an essential building block for cholesterol and triglyceride biosynthesis (Sun et al., 2010) . For triglyceride synthesis, less acetyl CoA availability in broiler chickens treated with curcumin may lead to a decrease in the liver TG concentration. This leads to the reasonable hypothesis that curcumin directly stimulates the β-oxidation pathway in hepatocytes, increasing the uptake of the released NEFA and catalyzing the conversion of TG to fatty acids and glycerol. In addition, HL is an important lipid metabolic enzyme in the liver (Kuusi et al., 1980; Herbst et al., 2003) , and our results showed an obvious increase in HL activity after supplementation with curcumin. Comprehensive results in this study have suggested that curcumin supplementation in the diet could decrease abdominal fat deposition in broiler chickens by regulating the related gene expression.
The present study also showed that curcumin decreased absolute and relative abdominal fat weights. Fat accumulation is a complex process associated with many alterations of the expression of lipogenesis and lipolysis genes. Fatty acid production requires acetyl CoA, which arises from the extramitochondrial cleavage of citrate catalyzed by ACLY. Acetyl CoA is substrate for acetyl CoA carboxylase and a primer for fatty acid synthase, which uses the malonyl-CoA produced by acetyl CoA carboxylase for fatty acid biosynthesis. The experiment of ACC2 knockout mice has demonstrated that the body fat and weight were decreased compared with the normal mice (Abu-Elheiga et al., 2001 . In the present result, curcumin supplementation significantly decreased the ACC expression, which catalyzes the formation of malonyl-CoA from acetyl-CoA. This is explained by the decreasing activity of ACC that causes a subsequent decrease in malonyl-CoA concentrations and in turn prevents inhibition of CPT-I leading to the increased fatty acid oxidation (Shi et al., 2000; Abu-Elheiga et al., 2003) . Previous studies have shown that SREBP protein can regulate cholesterol and fatty acid biosynthesis in the liver by directly stimulating the transcription of fatty acid synthase (Brown and Goldstein, 1997; Stoeckman and Towle, 2002; Kong et al., 2004; Ricketts et al., 2005; Bursill and Roach, 2006) . In the present study, curcumin supplementation significantly decreased the gene expression level of ACC, FAS, and SREBP-1c. These results indicated that these genes might be directly responsible for the effect of curcumin on fatty acid synthesis and lipogenesis in broiler chickens. In addition, the gene expression level of PPARα and CPT-1 was significantly upregulated in broiler chicken liver tissue. Considering the decreased TG content in serum and liver after curcumin treatment, gene expression of PPARα and CPT-1 was increased in the liver. PPARα and CPT-I is a key gene in control mitochondrial, peroxisomal fatty acid oxidation, and beta-oxidation of fatty acids (Schoonjans et al., 1996; Louet et al., 2001; Kersten, 2002) .
CONCLUSIONS
These results showed that curcumin plays an important role in reduction abdominal fat deposition by decreasing the hepatic and plasma lipid profile and affecting the expression levels of genes related to lipogenesis and lipolysis including ACC, FAS, SREBP-1c, ACLY, PPARα, and CPT-I.
